| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H26FN3O3 |
| Molecular Weight | 363.4264 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@@H](NC(=O)C1=NN(CCCCCF)C2=CC=CC=C12)C(C)C
InChI
InChIKey=SAFXSUZMRLTBMM-INIZCTEOSA-N
InChI=1S/C19H26FN3O3/c1-13(2)16(19(25)26-3)21-18(24)17-14-9-5-6-10-15(14)23(22-17)12-8-4-7-11-20/h5-6,9-10,13,16H,4,7-8,11-12H2,1-3H3,(H,21,24)/t16-/m0/s1
| Molecular Formula | C19H26FN3O3 |
| Molecular Weight | 363.4264 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 7.99 null [pEC50] | |||
| 8.71 null [pEC50] |
